Rivastigmine Tartrate 75834-0135-60
- Manufacturer
- Nivagen Pharmaceuticals, Inc.
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- September 4, 2017
- Listing Expires
- December 31, 2026
- Application
- ANDA203844
Need to source Rivastigmine Tartrate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Rivastigmine Tartrate | 4.5 mg/1 |
Drug Class
Cholinesterase Inhibitor [EPC]Cholinesterase Inhibitors [MoA]
Selected Package
75834-0135-60Selected60 CAPSULE in 1 BOTTLE, PLASTIC (75834-135-60)
Other packages for this product(1)
500 CAPSULE in 1 BOTTLE, PLASTIC (75834-135-05)